USIL Therapeutics SA
USIL Therapeutics is a Luxembourg-based biotechnology company developing next-generation medical countermeasures against the effects of ionizing radiation. Focused on acute radiation syndrome (ARS) and broader radiological preparedness, the company is advancing patented whole-body radioprotective solutions designed for civilian healthcare, emergency response, nuclear safety, aerospace, and strategic resilience applications. USIL Therapeutics combines expertise in radiobiology, drug […]









